Kaliner M, Austen K F
J Exp Med. 1973 Nov 1;138(5):1077-94. doi: 10.1084/jem.138.5.1077.
Five sequential steps interspaced between the antigen activation of human lung fragments sensitized with IgE and the release of the chemical mediators, histamine and slow-reacting substance of anaphylaxis (SRS-A), have been delineated. The experimental design that permits this analysis is based upon the capacity to maintain the serine esterase essential to mediator release in its diisopropylphosphofluoridate (DFP)-resistant precursor state despite antigen challenge and upon the ability to arrest reversibly the reaction sequence by various manipulations. When sensitized lung fragments are challenged with antigen in the presence of DFP, a serine esterase is converted to its active DFP-inhibitable state; this conversion is prevented if antigen challenge in the presence of DFP occurs in calcium-free buffer indicating that immunologic activation of the esterase requires extracellular calcium. The fact that calcium depletion alone does not impair antigen-induced histamine release implies that prevention of esterase activation depends upon both the absence of extracellular calcium and the inactivation of any active esterase by DFP to prevent an autocatalytic feedback activation. Arresting the antigen-induced activation of the serine esterase by the combination of DFP in calcium-free buffer precludes the sequence from reaching the labile, 2-deoxyglucose (2-DG)-inhibitable, energy-requiring step, indicating that proesterase activation precedes this energy-requiring stage. The 2-DG-inhibitable step precedes a second calcium-requiring, EDTA-inhibitable stage, as EDTA prevents glucose reversal of 2-DG inhibition of antigen-challenged tissue, while the presence of 2-DG does not prevent calcium reversal of EDTA inhibition. The finding that isoproterenol prevents calcium reversal of EDTA inhibition of mediator release suggests that the inhibitory site of action of increased concentrations of cyclic AMP is coincident with or subsequent to the second calcium-requiring, EDTA-inhibitable step. Therefore, the sequence of biochemical events initiated by the interaction of antigen with tissue-fixed IgE antibodies appears to proceed from the calcium-requiring activation of a DFP-sensitive serine esterase; the further autocatalytic activation of the esterase; a 2-DG-inhibitable energy requirement; a second calcium-requiring, EDTA-inhibitable stage; and a cyclic AMP-inhibitable step to the release of histamine and SRS-A.
在IgE致敏的人肺组织片段的抗原激活与化学介质组胺和过敏反应慢反应物质(SRS - A)释放之间,已明确了五个连续步骤。允许进行此分析的实验设计基于以下能力:尽管存在抗原攻击,但仍能将介质释放所必需的丝氨酸酯酶维持在其二异丙基磷氟酸盐(DFP)抗性前体状态;以及通过各种操作可逆地阻止反应序列的能力。当在DFP存在下用抗原攻击致敏的肺组织片段时,一种丝氨酸酯酶会转变为其活性的DFP可抑制状态;如果在无钙缓冲液中存在DFP时进行抗原攻击,则这种转变会被阻止,这表明酯酶的免疫激活需要细胞外钙。单独的钙耗竭并不损害抗原诱导的组胺释放这一事实意味着,酯酶激活的预防取决于细胞外钙的缺失以及DFP对任何活性酯酶的失活,以防止自催化反馈激活。通过在无钙缓冲液中联合使用DFP来阻止抗原诱导的丝氨酸酯酶激活,可防止反应序列进入不稳定的、2 - 脱氧葡萄糖(2 - DG)可抑制的、需要能量的步骤,这表明前酯酶激活先于此需要能量的阶段。2 - DG可抑制步骤先于第二个需要钙的、EDTA可抑制阶段,因为EDTA可防止葡萄糖逆转2 - DG对抗原攻击组织的抑制作用,而2 - DG的存在并不能防止钙逆转EDTA的抑制作用。异丙肾上腺素可防止钙逆转EDTA对介质释放的抑制作用这一发现表明,环磷酸腺苷浓度增加的抑制作用位点与第二个需要钙的、EDTA可抑制步骤一致或在其后。因此,由抗原与组织固定的IgE抗体相互作用引发的生化事件序列似乎从需要钙的DFP敏感丝氨酸酯酶激活开始;酯酶的进一步自催化激活;一个2 - DG可抑制的能量需求;第二个需要钙的、EDTA可抑制阶段;以及一个环磷酸腺苷可抑制步骤,直至组胺和SRS - A的释放。